Human Medical Sequencing Program and Current Initiatives

National Human Genome Research Institute

National Institutes of Health
U.S. Department of Health and Human Services


Spider web

Archived Page

This page is an archive and is provided for historical reference purposes only. The content and links are no longer maintained and may now be outdated.

Human Medical Sequencing Program and Current Initiatives

Program Rationale

With the completion of the human genome sequence, and the acquisition of the genomic sequences of a number of other organisms for the purpose of aiding the annotation of the human sequence, the National Human Genome Research Institute (NHGRI) now intends to harness the power of its large-scale sequencing program to reach the long-range objective of making human DNA sequencing a tool for both research and medical practice. As more is learned from sequencing and other studies about the genomic contribution to disease, and as the cost of obtaining sequence information decreases, genomic sequence information will become ever more important both for biomedical research and for providing medically relevant information to individuals. When it becomes affordable for an individual's genome to be fully sequenced, the information obtained will allow estimates of future disease risk and improve the prevention, diagnosis, and treatment of disease.

The Institute is particularly interested in defining a sequencing program that will both drive technology and produce data useful to biomedical research at all stages along the way. It is anticipated that this program will include efforts to obtain genomic sequence data from many individuals with known phenotypes, as such data will be critical for addressing a wide range of questions important for advancing biomedicine.

In addition to the Medical Sequencing Program (MSP) initiatives described here, there is a related NHGRI initiative, the The Cancer Genome Atlas, which is a separate collaboration between the National Cancer Institute and NHGRI.

Finally, there are two trans-NIH genotyping initiatives, the Genetics Association Information Network (GAIN) and the Genes, Environment and Health Initiative (GEI), which have some similar features.

Top of page

Medical Sequencing Program Initiatives

Top of page

Approved Medical Sequencing Projects

Top of page

How to Access Medical Sequencing Data

Medical sequence data produced under NHGRI funding are available through a tiered repository maintained by the National Center for Biotechnology Information or by the National Cancer Institute Center for Bioinformatics for cancer sequencing projects. Fragmentary sequence data and minimal phenotype data that cannot be used to identify a participant will be released to an open repository. Information enabling the association of fragmentary sequence data, and associated phenotype data will be available only to biomedical researchers through a controlled access repository. Access to the controlled-access database requires NHGRI review and approval of a Data Access Request.

Top of page

Process for Selecting New Medical Sequencing Targets

In 2005, NHGRI convened a Medical Sequencing Working Group (MSWG) to help it chart a course towards the aims described above. The MSWG has been charged with providing general advice on how the program should evolve and specific advice about projects that NHGRI should pursue in the near term with its existing sequencing capacity. The MSWG is also charged with providing guidance on setting policies for ethical, legal, and social issues arising from the program.

All sequencing targets and rationales proposed by the MSWG are assessed by the Coordinating Committee for sequencing target selection and by the National Advisory Council on Human Genome Research.

A roster of MSWG members is available here:

Top of page

Opportunities for New Medical Sequencing Proposals

Top of page

Medical Sequencing Policies

In the course of implementing the medical sequencing pilot projects, NHGRI has developed a detailed and extensive set of Medical Sequencing Policies and Data Access Policies that describe procedures for the provision of samples; appropriate informed consent for research participants; deposition and release of data; and access to medical sequencing data. These policies differ significantly from those used for the Human Genome Project, and for organismal sequencing, due to the requirements for the protection of research participants.

Top of page

Program Contacts

Adam Felsenfeld, Ph.D.
Program Director
E-mail: felsenfa@mail.nih.gov

Jane Peterson, Ph.D.
Associate Director, DER
E-mail: petersoj@mail.nih.gov

Top of page

Last Reviewed: June 5, 2012